ArticleActa pharmaceutica Sinica. B2021

Discovery of an orally active VHL-recruiting PROTAC that achieves robust HMGCR degradation and potent hypolipidemic activity

Guoshun Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.